Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...
Section 6225 of the Consolidated Appropriations Act of 2026 (CAA 2026), enacted on February 3, 2026, fundamentally changes Medicare's treatment of hospital off-campus provider-based departments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results